Medical Department, Ev.-Jung-Stilling Hospital, Academic Hospital of the University of Bonn, Siegen, Germany;, Cattedra di Gastroenterologia, Dipartimento di Scienze Mediche, ...
KOL Resume for Andreas Leodolter
Medical Department, Ev.-Jung-Stilling Hospital, Academic Hospital of the University of Bonn, Siegen, Germany;, Cattedra di Gastroenterologia, Dipartimento di Scienze Mediche, University of Milan, and Fondazione IRCCS Ospedale Maggiore, Mangiagalli, Regina Elena, Milan, Italy
Prominent publications by Andreas Leodolter
On-demand proton pump inhibitor (PPI) therapy is an attractive option for long-term management of gastroesophageal reflux disease (GERD). Controlled trials in non-erosive reflux disease (NERD) patients have shown sufficient symptom control in most patients with a high rate of willingness to continue treatment and substantial saving on PPI expenditure. However, due to the slow onset of action of PPIs, rescue antacids are often used when symptoms recur and several patients continue to ...
|Known for Demand Therapy | Gastroesophageal Reflux Disease | Proton Pump | Nerd Patients | Reflux Humans|
Barrett's Esophagus and Cytokine Polymorphisms—Confusion about the Content in the Abstract/Results Section Compared to the Table Given in a Recent Manuscript
[ PUBLICATION ]
|Known for Barrett Esophagus | Esophageal Neoplasms|
Key People For Demand Therapy
Andreas Leodolter:Expert Impact
Concepts for whichAndreas Leodolterhas direct influence:Demand therapy, Gastroesophageal reflux disease, Demand treatment, Nerd patients, Gastroesophageal reflux, Reflux disease, Disease gerd, Adenocarcinoma barrett.
Andreas Leodolter:KOL impact
Concepts related to the work of other authors for whichfor which Andreas Leodolter has influence:Gastric mucosa, Gastroesophageal reflux disease, Precancerous condition, Acid suppression, Omeprazole monotherapy, Hyperplastic polyp, Endoscopic management.
Is this your profile? Claim your profile Copy URL Embed Link to your profile